Advancing Treatment for Non-Melanoma Skin Cancer

Patients

Information about non-melanoma skin cancer and available treatment options.

Read more
Healthcare Professionals

Clinical information about Rhenium-SCT, including treatment principles and clinical use.

Click here
Treatment Centres

Looking for a Rhenium-SCT treatment centre? Click here to find a local clinic near you.

Find a location
OncoBeta combines advanced radioisotope technology with clinical expertise to enable precise, localised treatment. Our platform supports reliable access to key isotopes such as rhenium 188 and their use in clinical practice.

Transforming care through targeted radiopharmaceutical innovation

OncoBeta is a medical device and radiochemical company focused on advancing targeted therapies for non-melanoma skin cancer. Through technologies such as Rhenium-SCT, we deliver precise radioisotope treatments designed to improve patient outcomes while preserving healthy tissue.

Driven by scientific expertise and a commitment to patient-centred care, we develop and commercialise innovative solutions that expand the therapeutic potential of isotopes like rhenium 188 – bringing effective, scalable treatments to patients worldwide.

More about OncoBeta

Innovative therapy for non-melanoma skin cancer

Rhenium-SCT may be considered for the treatment of non-melanoma skin cancer. This therapy uses the radioisotope rhenium 188 to deliver beta radiation to cancer cells while preserving healthy tissue.1

Rhenium-SCT improves outcomes and the quality of life of non-melanoma skin cancer patients.2,3,4 OncoBeta is working with medical, scientific and industrial partners as well as local and national authorities to make this personalised*, painless† and non-invasive‡ therapy accessible to patients all over the world.1,2,5

Discover Rhenium-SCT

Designed Around the Patient

OncoBeta supports patients with a non-invasive‡ treatment option for non-melanoma skin cancer.2 This approach aims to lower treatment burden while supporting quality of life – helping patients return to everyday living.

Find a Rhenium-SCT treatment centre

Have you been diagnosed with non-melanoma skin cancer? Rhenium-SCT is available in locations around the world. Find a treatment centre near you.
Find a location

Contact form

Contact us

Do you have a question about OncoBeta, our products, or non-melanoma skin cancer therapy with Rhenium-SCT? Talk to us today.

* Accurate dosing. Spares healthy tissue.5

† No pain reported during procedure.2

‡ No direct skin contact or incisions.2

References:

  1. Cardaci G, et al. Adv Radiat Oncol. 2025;10(7):101802.
  2. Castellucci P, et al. Eur J Nucl Med Mol Imaging. 2021;48(5):1511–1521.
  3. Sedda AF, et al. Clin Exp Dermatol. 2008;33(6):745–749.
  4. Baxi S, et al. J Nuc Med. 2024;00:1–6 DOI: 10.2967/jnumed.124.267988.
  5. Cipriani C, et al. J Dermatol Treat. 2022;33(2):969–975. Epub 22 Jul 2020.